We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GMHS:NASDAQGamehaus Holdings Inc. Analysis

Data as of 2026-06-07 - not real-time

$0.94

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $0.94, just below its 20‑day SMA of 0.98 and edging toward a key support level around $0.80, while the 50‑day SMA sits at 0.98 and the 200‑day SMA is markedly higher at 1.12, indicating a neutral to slightly bearish short‑term bias. Technical signals such as a bearish MACD histogram and an RSI of 45 suggest momentum is fading, even though volume is on the rise, which could accelerate a move toward the support zone.
Fundamentally, GMHS posted a 7.8% revenue decline and thin operating (3.3%) and profit margins (4.3%), with operating and free cash flow both at zero, highlighting cash‑flow weakness. The price‑to‑earnings ratio of 10.4 is well below the industry average of 17, implying a potentially undervalued valuation, yet the company carries a debt‑to‑equity of 1.6 and no dividend, underscoring financial fragility.
Risk factors are pronounced: 30‑day price volatility exceeds 58%, beta is slightly negative (‑0.23) indicating low market correlation but also erratic price behavior, and the gaming sector in China faces high regulatory scrutiny. Geographic concentration in China and exposure to USD/CNY exchange rates add medium currency risk, while a market cap of only $53.8 M and modest average volumes raise liquidity concerns.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below 20‑day SMA
  • Approaching key support level near $0.80
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued PE relative to industry peers
  • Continued revenue decline and zero cash flow
  • High regulatory and sector risk in Chinese gaming

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if regulatory environment eases
  • Persistent cash‑flow weakness and debt burden
  • Long‑term valuation appeal versus peers

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin4.31%
P/E Ratio10.4
Debt/Equity1.60
P/B Ratio1.4
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI45.2
Support$0.80
Resistance$1.05
MA 20$0.98
MA 50$0.98
MA 200$1.12
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.23
Volatility58.74%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.